|
MechanismBcl-2 inhibitors |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Genta Development Limited
0 Patents (Medical) associated with Genta Development Limited
100 Deals associated with Genta Development Limited
100 Translational Medicine associated with Genta Development Limited